美股異動 | Rivian漲8% 與梅賽德斯-奔馳合作
格隆匯9月8日丨Rivian(RIVN.US)漲8.06%,報35.93美元,總市值329億美元。消息面上,梅塞德斯-奔馳和Rivian將在歐洲的聯合工廠生產麪包車。兩家公司設想在普通裝配線上進行生產優化的車輛設計,以實現高效製造。梅賽德斯-奔馳和Rivian將致力於生產兩款大型貨車--一款基於梅賽德斯-奔馳麪包車的純電動平台,另一款基於第二代Rivian輕型貨車平台。這家德國汽車製造商和美國電動汽車upstart也將探索進一步提高合資企業協同效應的選擇。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.